Skip to content

Clinical study of gene chip in patients with severe pneumonia

Clinical study of gene chip in patients with severe pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017234
Enrollment
Unknown
Registered
2018-07-19
Start date
2018-07-17
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe pneumonia

Interventions

combined group:pathogenic gene chip detection and pathogenic detection
control group:pathogenic detection

Sponsors

Ningde municipal hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Provide signed informed consent, aged 18 to max years, clinical symptoms suggestive of community-acquired pneumonia, acquired outside of the hospital or less than 48 hours after hospital admission, met SCAP criteria (defined by the American Thoracic Society) fulfilled three or more of the following criteria: PaO2/FiO2 ratio =250 mmHg, respiratory rate =30 breaths/min, blood urea nitrogen (BUN) >20 mg/dL, leukopenia (white blood cell count (WBC) <4000 cells/ mm3) not due to other causes, thrombocytopenia (platelet count<100,000 cells/mm3), hypothermia (core temperature <36 degree C), new onset mental confusion, receiving treatment with vasopressors at therapeutic doses after adequate fluid resuscitation, or radiographic findings on new pulmonary infiltrate(s) consistent with CAP diagnosis. Patients with pneumonia of sufficient severity requiring ICU management and patients meeting at least one of the severity criteria, such as receiving mechanical ventilatory support or septic shock with the need for vasopressors, were also included in the study).

Exclusion criteria

Exclusion criteria: Life expectancy was 48 hours or less, pregnant or lactating, diagnosed with lung tumors,acute myocardial infarction and stock could not complete the study judged by investigators.

Design outcomes

Primary

MeasureTime frame
mortality;Index related with inflammation;Hospitalization time;

Countries

China

Contacts

Public ContactCanhui Zhang

Ningde municipal hospital Affiliated to Fujian Medical University

ndsyyzch@163.com+86 13950579772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026